These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32669285)

  • 21. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
    Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
    JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
    [No Abstract]   [Full Text] [Related]  

  • 22. Patients with cancer in the COVID-19 era: the clinical trial issue.
    Scarcia M; Ludovico GM; Fortunato A; Fiorentino A
    Tumori; 2020 Aug; 106(4):271-272. PubMed ID: 32508257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
    Moskowitz CS; Panageas KS
    JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
    [No Abstract]   [Full Text] [Related]  

  • 24. China is tightening its grip on coronavirus research.
    Silver A; Cyranoski D
    Nature; 2020 Apr; 580(7804):439-440. PubMed ID: 32296161
    [No Abstract]   [Full Text] [Related]  

  • 25. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
    Borno HT; Small EJ
    Contemp Clin Trials; 2020 May; 92():105997. PubMed ID: 32272172
    [No Abstract]   [Full Text] [Related]  

  • 26. When a global pandemic complicates cancer care: Although oncologists and their patients are accustomed to fighting tough battles against a lethal disease, Coronavirus Disease 2019 (COVID-19) has posed an unprecedented challenge.
    Printz C
    Cancer; 2020 Jul; 126(14):3171-3173. PubMed ID: 32584455
    [No Abstract]   [Full Text] [Related]  

  • 27. Foreword.
    Martin RF
    Surg Clin North Am; 2020 Jun; 100(3):xiii-xiv. PubMed ID: 32402309
    [No Abstract]   [Full Text] [Related]  

  • 28. Telemedicine Use in Oncology Practices.
    Baum NH
    Oncology (Williston Park); 2020 Jul; 34(7):280-282. PubMed ID: 32674217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 research: promising tracks leading to uro-oncology.
    Tamás F; Tibor S; Anita C; Boris H; Péter N
    Int Urol Nephrol; 2020 Jun; 52(6):995-997. PubMed ID: 32394243
    [No Abstract]   [Full Text] [Related]  

  • 30. Perfusion's Role in Responding to the COVID-19 Pandemic.
    Schiess JG
    J Extra Corpor Technol; 2020 Mar; 52(1):5-6. PubMed ID: 32280138
    [No Abstract]   [Full Text] [Related]  

  • 31. The Impact of COVID-19 on Diabetes Research in Canada.
    Dyck JRB
    Can J Diabetes; 2020 Jul; 44(5):369. PubMed ID: 32405267
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 Ethics and Research.
    Meagher KM; Cummins NW; Bharucha AE; Badley AD; Chlan LL; Wright RS
    Mayo Clin Proc; 2020 Jun; 95(6):1119-1123. PubMed ID: 32402511
    [No Abstract]   [Full Text] [Related]  

  • 33. Conducting Clinical Research in the Era of Covid-19.
    Perez T; Perez RL; Roman J
    Am J Med Sci; 2020 Sep; 360(3):213-215. PubMed ID: 32690272
    [No Abstract]   [Full Text] [Related]  

  • 34. Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity.
    Fleming TR; Labriola D; Wittes J
    JAMA; 2020 Jul; 324(1):33-34. PubMed ID: 32463422
    [No Abstract]   [Full Text] [Related]  

  • 35. Oncology Clinical Trials During the COVID-19 Pandemic.
    Lara Gongoria AB; Fontes Jardim DL; Bastos DA
    Oncology (Williston Park); 2020 Jul; 34(7):265-269. PubMed ID: 32674214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The urgent need for integrated science to fight COVID-19 pandemic and beyond.
    Moradian N; Ochs HD; Sedikies C; Hamblin MR; Camargo CA; Martinez JA; Biamonte JD; Abdollahi M; Torres PJ; Nieto JJ; Ogino S; Seymour JF; Abraham A; Cauda V; Gupta S; Ramakrishna S; Sellke FW; Sorooshian A; Wallace Hayes A; Martinez-Urbistondo M; Gupta M; Azadbakht L; Esmaillzadeh A; Kelishadi R; Esteghamati A; Emam-Djomeh Z; Majdzadeh R; Palit P; Badali H; Rao I; Saboury AA; Jagan Mohan Rao L; Ahmadieh H; Montazeri A; Fadini GP; Pauly D; Thomas S; Moosavi-Movahed AA; Aghamohammadi A; Behmanesh M; Rahimi-Movaghar V; Ghavami S; Mehran R; Uddin LQ; Von Herrath M; Mobasher B; Rezaei N
    J Transl Med; 2020 May; 18(1):205. PubMed ID: 32430070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian Experience.
    Curigliano G
    Oncologist; 2020 Jun; 25(6):463-467. PubMed ID: 32298029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncology care in a lower middle-income country during the COVID-19 pandemic.
    Trehan A; Jain R; Bansal D
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28438. PubMed ID: 32542968
    [No Abstract]   [Full Text] [Related]  

  • 39. Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
    Postel-Vinay S; Massard C; Soria JC
    Eur J Cancer; 2020 Sep; 137():235-239. PubMed ID: 32805640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain.
    Manso L; De Velasco G; Paz-Ares L
    ESMO Open; 2020 Jun; 4(Suppl 2):e000828. PubMed ID: 32571808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.